Please assess the completion status of the following clinical trial:

Trial Title: Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~1. Women aged ≥18 years diagnosed with histologically verified CIN 3 and women aged ≥ 30 years diagnosed with CIN 2~2. Satisfactory colposcopy~3. Signed informed consent~4. Negative pregnancy test~5. Appropriate contraception method for fertile women during active study period~6. Adequate compliance~Exclusion criteria:~1. Adenocarcinoma in situ~2. History of previous conization~3. Malignant disease at the time of inclusion~4. Colposcopy suspicious for invasive disease~5. Pregnancy and lactation period~6. Known allergy or intolerance to IMQ~7. Contraindications to conization or IMQ~8. Symptoms of a clinically relevant disease~9. Known HIV infection~10. Evidence of a clinically significant immunodeficiency~11. Current, reported participation in another experimental, interventional protocol

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Topical Imiquimod (Type: EXPERIMENTAL): 16 weeks topical Imiquimod
- Conization (Type: ACTIVE_COMPARATOR): Large loop excision of the transformation zone

Based on this trial design, predict the completion outcome and termination type (if applicable).